Immunotherapy With TG4010 in Patients With Advanced Non-Small Cell Lung Cancer

Clinical trial NCT00415818 · COMPLETED

Trial details

NCT number: NCT00415818
Sponsor: Transgene
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Carcinoma, Non-Small-Cell Lung

Start date: 2005-12-01
Primary completion: 2010-03-01
Enrollment: 148

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.